Company
OUE Healthcare Limited
SGX Catalist:5WA
Qualifies on both limbs: listed on SGX Catalist under 5WA and headquartered in Singapore. It is an investment holding company that owns, operates and invests in healthcare businesses across Singapore, China, Myanmar, Indonesia and Japan, running hospitals and specialist clinics, supplying medical equipment and pharmaceuticals, and holding healthcare property and development assets. Parent is OUE Limited. Its longevity relevance is indirect and infrastructural rather than biological: it is a private healthcare services operator, not a developer of ageing-targeted therapeutics or diagnostics. The nearest direct link is its stated push into specialised care and an integrative medicine offering combining traditional and Western treatment, which sits adjacent to preventive and wellness-oriented care. There is no disclosed geroscience, senolytic, biological-age testing or longevity-clinic programme. Treat it as a delivery-channel holding in the SG universe, not an intervention developer. Financial scale was not verified: the shares traded around SGD 0.03 on 17 July 2026 per StockAnalysis, but no market capitalisation figure was retrieved, so that field is left null rather than estimated.
At a glance
- Listing
- SGX Catalist:5WA
- Category
- Healthtech
- Headquarters
- Singapore (6 Shenton Way, Singapore 068809)
- Market cap
- Not disclosed
Thesis
Why it is in this universe
- Category
- Healthtech
- Market
- Singapore
- Recent inflection
- At its annual general meeting on 24 April 2026 (minutes lodged with SGX on 22 May 2026), management reiterated a three-part strategy of an asset-light model, strategic partnerships and regional Asian expansion, and flagged a shift toward specialised care including a planned integrative medicine service combining traditional and Western treatment. Source: SGX-hosted AGM minutes, https://links.sgx.com/FileOpen/OUEH%20-%20Minutes%20of%20AGM%20held%20on%2024%20April%202026.ashx?App=Announcement&FileID=889933
- Services
- None recorded
- People tracked
- None on file
Market data
Listing and scale
| Metric | Detail |
|---|---|
| Exchange | SGX Catalist |
| Ticker | SGX Catalist:5WA |
| Secondary listing | None |
| Market cap | Not disclosed |
| Status | Listed and trading |
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.
Get in touch
Contact
- Address
- Singapore (6 Shenton Way, Singapore 068809)
- Website
- sginvestors.io
- Phone
- No public number published
- No public address published
Offering
What it sells today
No commercial services are recorded for this company yet.
Recent inflection
What moved lately
At its annual general meeting on 24 April 2026 (minutes lodged with SGX on 22 May 2026), management reiterated a three-part strategy of an asset-light model, strategic partnerships and regional Asian expansion, and flagged a shift toward specialised care including a planned integrative medicine service combining traditional and Western treatment. Source: SGX-hosted AGM minutes, https://links.sgx.com/FileOpen/OUEH%20-%20Minutes%20of%20AGM%20held%20on%2024%20April%202026.ashx?App=Announcement&FileID=889933
Keep reading
Related coverage from the newsroom.
Sources
What this profile is built on
- SGX-listed healthcare sector stocks (IHH Healthcare Berhad, SGX: Q0F) · SGinvestors.io
- OUE Healthcare (SGX:5WA) company profile: Singapore HQ, SGX Catalist listing, segments, price as of 17 July 2026 · StockAnalysis
- Minutes of AGM held on 24 April 2026 · Singapore Exchange (SGX) announcements
- OUE Healthcare 2026 Annual General Meeting presentation · Singapore Exchange (SGX) announcements
Every entity profile on variis is sourced. Not investment advice.